{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:45:37Z","timestamp":1790952337597,"version":"4.1.0"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10787-022-00992-2","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T03:57:48Z","timestamp":1651636668000},"page":"789-798","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":128,"title":["COVID-19 and the role of cytokines in this disease"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0837-7542","authenticated-orcid":false,"given":"Amin","family":"Hasanvand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"issue":"9","key":"992_CR1","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1111\/all.14866","volume":"76","author":"S Adamo","year":"2021","unstructured":"Adamo S, Chevrier S, Cervia C, Zurbuchen Y, Raeber ME, Yang L et al (2021) Profound dysregulation of T cell homeostasis and function in patients with severe COVID-19. Allergy 76(9):2866\u20132881","journal-title":"Allergy"},{"issue":"4","key":"992_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.53986\/ibjm.2020.0058","volume":"2","author":"BJ Alegbeleye","year":"2020","unstructured":"Alegbeleye BJ, Akpoveso O-OP, Alegbeleye AJ, Mohammed RK, Esteban-Zubero E (2020) The novel aspirin as breakthrough drug for COVID-19: a narrative review. Iberoam J Med 2(4):335\u2013350","journal-title":"Iberoam J Med"},{"issue":"3","key":"992_CR3","first-page":"911","volume":"18","author":"MA Al-Rawi","year":"2003","unstructured":"Al-Rawi MA, Mansel RE, Jiang WG (2003) Interleukin-7 (IL-7) and IL-7 receptor (IL-7R) signalling complex in human solid tumours. Histol Histopathol 18(3):911\u2013923","journal-title":"Histol Histopathol"},{"issue":"5","key":"992_CR4","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2017.01.006","volume":"38","author":"N Amatya","year":"2017","unstructured":"Amatya N, Garg AV, Gaffen SL (2017) IL-17 signaling: the Yin and the Yang. Trends Immunol 38(5):310\u2013322","journal-title":"Trends Immunol"},{"issue":"6508","key":"992_CR5","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"PS Arunachalam","year":"2020","unstructured":"Arunachalam PS, Wimmers F, Mok CKP, Perera R, Scott M, Hagan T et al (2020) Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science 369(6508):1210\u20131220","journal-title":"Science"},{"issue":"4","key":"992_CR6","doi-asserted-by":"publisher","first-page":"e002285","DOI":"10.1136\/jitc-2020-002285","volume":"9","author":"PA Ascierto","year":"2021","unstructured":"Ascierto PA, Fu B, Wei H (2021) IL-6 modulation for COVID-19: the right patients at the right time? J Immunother Cancer 9(4):e002285","journal-title":"J Immunother Cancer"},{"issue":"10","key":"992_CR7","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jcph.1874","volume":"61","author":"S Assadiasl","year":"2021","unstructured":"Assadiasl S, Fatahi Y, Mosharmovahed B, Mohebbi B, Nicknam MH (2021) Baricitinib: from rheumatoid arthritis to COVID-19. J Clin Pharmacol 61(10):1274\u20131285","journal-title":"J Clin Pharmacol"},{"key":"992_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155627","volume":"146","author":"SN Avdeev","year":"2021","unstructured":"Avdeev SN, Trushenko NV, Tsareva NA, Yaroshetskiy AI, Merzhoeva ZM, Nuralieva GS et al (2021) Anti-IL-17 monoclonal antibodies in hospitalized patients with severe COVID-19: a pilot study. Cytokine 146:155627","journal-title":"Cytokine"},{"issue":"2","key":"992_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1006\/viro.1996.0484","volume":"223","author":"M Barna","year":"1996","unstructured":"Barna M, Komatsu T, Reiss CS (1996) Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection. Virology 223(2):331\u2013343","journal-title":"Virology"},{"issue":"3","key":"992_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.cyto.2013.04.036","volume":"63","author":"E Bartee","year":"2013","unstructured":"Bartee E, McFadden G (2013) Cytokine synergy: an underappreciated contributor to innate anti-viral immunity. Cytokine 63(3):237\u2013240","journal-title":"Cytokine"},{"key":"992_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.737406","volume":"12","author":"Y Bekele","year":"2021","unstructured":"Bekele Y, Sui Y, Berzofsky JA (2021) IL-7 in SARS-CoV-2 infection and as a potential vaccine adjuvant. Front Immunol 12:737406","journal-title":"Front Immunol"},{"key":"992_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2012.10.553","volume":"54","author":"A Bhattacharjee","year":"2013","unstructured":"Bhattacharjee A, Shukla M, Yakubenko VP, Mulya A, Kundu S, Cathcart MK (2013) IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes\/macrophages. Free Radic Biol Med 54:1\u201316","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"992_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M\u00f8ller R et al (2020) Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181(5):1036\u201345.e9","journal-title":"Cell"},{"key":"992_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.565470","volume":"11","author":"A Brevi","year":"2020","unstructured":"Brevi A, Cogrossi LL, Grazia G, Masciovecchio D, Impellizzieri D, Lacanfora L et al (2020) Much more than IL-17A: cytokines of the IL-17 family between microbiota and cancer. Front Immunol 11:565470","journal-title":"Front Immunol"},{"issue":"18","key":"992_CR15","doi-asserted-by":"publisher","first-page":"5091","DOI":"10.1158\/0008-5472.CAN-13-3171","volume":"74","author":"Y Cao","year":"2014","unstructured":"Cao Y, Slaney CY, Bidwell BN, Parker BS, Johnstone CN, Rautela J et al (2014) BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity. Cancer Res 74(18):5091\u20135102","journal-title":"Cancer Res"},{"issue":"11","key":"992_CR16","first-page":"1145","volume":"5","author":"FR Carlson Jr","year":"2020","unstructured":"Carlson FR Jr, Bosukonda D, Keck PC, Carlson WD (2020) Multiorgan damage in patients with COVID-19: is the TGF-\u03b2\/BMP pathway the missing link? Basic Transl Sci 5(11):1145\u20131148","journal-title":"Basic Transl Sci"},{"issue":"3","key":"992_CR17","doi-asserted-by":"publisher","first-page":"e02325","DOI":"10.1128\/mBio.02325-17","volume":"9","author":"C Casta\u00f1o-Rodriguez","year":"2018","unstructured":"Casta\u00f1o-Rodriguez C, Honrubia JM, Guti\u00e9rrez-\u00c1lvarez J, DeDiego ML, Nieto-Torres JL, Jimenez-Guarde\u00f1o JM et al (2018) Role of severe acute respiratory syndrome coronavirus viroporins E, 3a, and 8a in replication and pathogenesis. Mbio 9(3):e02325-e2417","journal-title":"Mbio"},{"issue":"12","key":"992_CR18","first-page":"2134","volume":"54","author":"G Cavalli","year":"2015","unstructured":"Cavalli G, Dinarello CA (2015) Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies. Rheumatology 54(12):2134\u20132144","journal-title":"Rheumatology"},{"issue":"6","key":"992_CR19","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/S2665-9913(20)30127-2","volume":"2","author":"G Cavalli","year":"2020","unstructured":"Cavalli G, De Luca G, Campochiaro C, Della-Torre E, Ripa M, Canetti D et al (2020) Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study. Lancet Rheumatol 2(6):e325\u2013e331","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"992_CR20","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1016\/S2665-9913(21)00012-6","volume":"3","author":"G Cavalli","year":"2021","unstructured":"Cavalli G, Larcher A, Tomelleri A, Campochiaro C, Della-Torre E, De Luca G et al (2021) Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study. Lancet Rheumatol 3(4):e253\u2013e261","journal-title":"Lancet Rheumatol"},{"issue":"11","key":"992_CR21","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.7150\/ijbs.46891","volume":"16","author":"W Chen","year":"2020","unstructured":"Chen W (2020) A potential treatment of COVID-19 with TGF-\u03b2 blockade. Int J Biol Sci 16(11):1954\u20131955","journal-title":"Int J Biol Sci"},{"issue":"10223","key":"992_CR22","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al (2020a) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395(10223):507\u2013513","journal-title":"Lancet"},{"issue":"6","key":"992_CR23","first-page":"471","volume":"36","author":"C Chen","year":"2020","unstructured":"Chen C, Zhang XR, Ju ZY, He WF (2020b) Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019. Zhonghua Shao Shang Za Zhi 36(6):471\u2013475","journal-title":"Zhonghua Shao Shang Za Zhi"},{"issue":"5","key":"992_CR24","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H et al (2020c) Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest 130(5):2620\u20132629","journal-title":"J Clin Invest"},{"issue":"3","key":"992_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-2567.2009.03244.x","volume":"130","author":"N Chetoui","year":"2010","unstructured":"Chetoui N, Boisvert M, Gendron S, Aoudjit F (2010) Interleukin-7 promotes the survival of human CD4+ effector\/memory T cells by up-regulating Bcl-2 proteins and activating the JAK\/STAT signalling pathway. Immunology 130(3):418\u2013426","journal-title":"Immunology"},{"issue":"6","key":"992_CR26","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/infdis\/jiv380","volume":"213","author":"H Chu","year":"2016","unstructured":"Chu H, Zhou J, Wong BH-Y, Li C, Chan JF-W, Cheng Z-S et al (2016) Middle East respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis 213(6):904\u2013914","journal-title":"J Infect Dis"},{"issue":"5","key":"992_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/microorganisms8050695","volume":"8","author":"M Colaneri","year":"2020","unstructured":"Colaneri M, Bogliolo L, Valsecchi P, Sacchi P, Zuccaro V, Brandolino F et al (2020) Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE). Microorganisms 8(5):695","journal-title":"Microorganisms"},{"issue":"2","key":"992_CR28","first-page":"327","volume":"34","author":"P Conti","year":"2020","unstructured":"Conti P, Ronconi G, Caraffa A, Gallenga C, Ross R, Frydas I et al (2020) Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies. J Biol Regul Homeost Agents 34(2):327\u2013331","journal-title":"J Biol Regul Homeost Agents"},{"key":"992_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cytogfr.2020.06.001","volume":"54","author":"VJ Costela-Ruiz","year":"2020","unstructured":"Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr\u00edguez L (2020) SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev 54:62\u201375","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"992_CR30","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1128\/jvi.69.3.1955-1958.1995","volume":"69","author":"JP Coutelier","year":"1995","unstructured":"Coutelier JP, Van Broeck J, Wolf SF (1995) Interleukin-12 gene expression after viral infection in the mouse. J Virol 69(3):1955\u20131958","journal-title":"J Virol"},{"issue":"1","key":"992_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.virol.2012.09.012","volume":"435","author":"MA Cox","year":"2013","unstructured":"Cox MA, Kahan SM, Zajac AJ (2013) Anti-viral CD8 T cells and the cytokines that they love. Virology 435(1):157\u2013169","journal-title":"Virology"},{"issue":"8","key":"992_CR32","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.1007\/s12035-021-02438-2","volume":"58","author":"DA Davies","year":"2021","unstructured":"Davies DA, Adlimoghaddam A, Albensi BC (2021) The effect of COVID-19 on NF-\u03baB and neurological manifestations of disease. Mol Neurobiol 58(8):4178\u20134187","journal-title":"Mol Neurobiol"},{"issue":"1","key":"992_CR33","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","volume":"11","author":"S De Biasi","year":"2020","unstructured":"De Biasi S, Meschiari M, Gibellini L, Bellinazzi C, Borella R, Fidanza L et al (2020) Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun 11(1):3434","journal-title":"Nat Commun"},{"issue":"2","key":"992_CR34","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1128\/JVI.02576-13","volume":"88","author":"ML DeDiego","year":"2014","unstructured":"DeDiego ML, Nieto-Torres JL, Regla-Nava JA, Jimenez-Guarde\u00f1o JM, Fernandez-Delgado R, Fett C et al (2014) Inhibition of NF-\u03baB-mediated inflammation in severe acute respiratory syndrome coronavirus-infected mice increases survival. J Virol 88(2):913\u2013924","journal-title":"J Virol"},{"issue":"3","key":"992_CR35","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/ijc.23993","volume":"124","author":"MZ Dewan","year":"2009","unstructured":"Dewan MZ, Tomita M, Katano H, Yamamoto N, Ahmed S, Yamamoto M et al (2009) An HIV protease inhibitor, ritonavir targets the nuclear factor-kappaB and inhibits the tumor growth and infiltration of EBV-positive lymphoblastoid B cells. Int J Cancer 124(3):622\u2013629","journal-title":"Int J Cancer"},{"key":"992_CR36","first-page":"2563","volume":"1843","author":"SK Dhar","year":"2020","unstructured":"Dhar SK, Vishnupriyan K, Damodar S, Gujar S, Das M (2020) IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. medRxiv 1843:2563","journal-title":"medRxiv"},{"key":"992_CR37","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao B, Wang C, Tan Y, Chen X, Liu Y, Ning L et al (2020) Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 11:827","journal-title":"Front Immunol"},{"key":"992_CR38","volume-title":"Treating inflammation by blocking interleukin-1 in humans. Seminars in immunology","year":"2013","unstructured":"Dinarello CA, van der Meer JW (eds) (2013) Treating inflammation by blocking interleukin-1 in humans. Seminars in immunology. Elsevier, Amsterdam"},{"issue":"19","key":"992_CR39","doi-asserted-by":"publisher","first-page":"2460","DOI":"10.1093\/bioinformatics\/btq461","volume":"26","author":"RC Edgar","year":"2010","unstructured":"Edgar RC (2010) Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26(19):2460\u20132461","journal-title":"Bioinformatics"},{"issue":"1","key":"992_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/15476910903453296","volume":"7","author":"N ElKassar","year":"2010","unstructured":"ElKassar N, Gress RE (2010) An overview of IL-7 biology and its use in immunotherapy. J Immunotoxicol 7(1):1\u20137","journal-title":"J Immunotoxicol"},{"issue":"23","key":"992_CR41","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"DC Fajgenbaum","year":"2020","unstructured":"Fajgenbaum DC, June CH (2020) Cytokine storm. N Engl J Med 383(23):2255\u20132273","journal-title":"N Engl J Med"},{"issue":"1","key":"992_CR42","first-page":"1","volume":"7","author":"AC Ferreira","year":"2021","unstructured":"Ferreira AC, Soares VC, de Azevedo-Quintanilha IG, Dias SDSG, Fintelman-Rodrigues N, Sacramento CQ et al (2021) SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov 7(1):1\u201312","journal-title":"Cell Death Discov"},{"key":"992_CR43","first-page":"36","volume":"11","author":"M Ferreira-Gomes","year":"2020","unstructured":"Ferreira-Gomes M, Kruglov A, Durek P, Heinrich F, Tizian C, Anne Heinz G et al (2020) In severe COVID-19, SARS-CoV-2 induces a chronic TGF-\u03b2-dominated adaptive immune response. medRxiv 11:36","journal-title":"medRxiv"},{"key":"992_CR44","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.98960","author":"B Francois","year":"2018","unstructured":"Francois B, Jeannet R, Daix T, Walton AH, Shotwell MS, Unsinger J et al (2018) Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.98960","journal-title":"JCI Insight"},{"key":"992_CR45","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/720305","volume":"2010","author":"Y Furuya","year":"2010","unstructured":"Furuya Y, Satoh T, Kuwana M (2010) Interleukin-6 as a potential therapeutic target for pulmonary arterial hypertension. Int J Rheumatol 2010:720305","journal-title":"Int J Rheumatol"},{"key":"992_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.virusres.2020.198171","volume":"289","author":"AC Gadotti","year":"2020","unstructured":"Gadotti AC, de Castro DM, Telles JP, Wind R, Goes M, Garcia CharelloOssoski R et al (2020) IFN-\u03b3 is an independent risk factor associated with mortality in patients with moderate and severe COVID-19 infection. Virus Res 289:191","journal-title":"Virus Res"},{"issue":"12","key":"992_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1224","volume":"9","author":"M Garc\u00eda","year":"2020","unstructured":"Garc\u00eda M, Kokkinou E, Carrasco Garc\u00eda A, Parrot T, Palma Medina LM, Maleki KT et al (2020) Innate lymphoid cell composition associates with COVID-19 disease severity. Clin Transl Immunol 9(12):e1224","journal-title":"Clin Transl Immunol"},{"key":"992_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cytogfr.2020.06.013","volume":"54","author":"B Goker Bagca","year":"2020","unstructured":"Goker Bagca B, Biray AC (2020) The potential of JAK\/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19. Cytokine Growth Factor Rev 54:51\u201362","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"992_CR49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/j.1752-8062.2008.00026.x","volume":"1","author":"AB Goldfine","year":"2008","unstructured":"Goldfine AB, Silver R, Aldhahi W, Cai D, Tatro E, Lee J et al (2008) Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 1(1):36\u201343","journal-title":"Clin Transl Sci"},{"issue":"1","key":"992_CR50","first-page":"93","volume":"22","author":"SI Grivennikov","year":"2005","unstructured":"Grivennikov SI, Tumanov AV, Liepinsh DJ, Kruglov AA, Marakusha BI, Shakhov AN et al (2005) Distinct and nonredundant in vivo functions of TNF produced by t cells and macrophages\/neutrophils: protective and deleterious effects. Immunity 22(1):93\u2013104","journal-title":"Immunity"},{"issue":"9","key":"992_CR51","doi-asserted-by":"publisher","first-page":"772","DOI":"10.3390\/v11090772","volume":"11","author":"Y Guo","year":"2019","unstructured":"Guo Y, Cao W, Zhu Y (2019) Immunoregulatory functions of the IL-12 family of cytokines in antiviral systems. Viruses 11(9):772","journal-title":"Viruses"},{"issue":"1","key":"992_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1001\/jamainternmed.2020.6252","volume":"181","author":"S Gupta","year":"2021","unstructured":"Gupta S, Wang W, Hayek SS, Chan L, Mathews KS, Melamed ML et al (2021) Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med 181(1):41\u201351","journal-title":"JAMA Intern Med"},{"issue":"1","key":"992_CR53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10787-020-00773-9","volume":"29","author":"A Hariharan","year":"2021","unstructured":"Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M (2021) The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients. Inflammopharmacology 29(1):91\u2013100","journal-title":"Inflammopharmacology"},{"issue":"4","key":"992_CR54","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1001\/jamacardio.2016.0605","volume":"1","author":"TH Hauser","year":"2016","unstructured":"Hauser TH, Salastekar N, Schaefer EJ, Desai T, Goldfine HL, Fowler KM et al (2016) Effect of targeting inflammation with salsalate: the TINSAL-CVD randomized clinical trial on progression of coronary plaque in overweight and obese patients using statins. JAMA Cardiol 1(4):413\u2013423","journal-title":"JAMA Cardiol"},{"issue":"10223","key":"992_CR55","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"issue":"7","key":"992_CR56","doi-asserted-by":"publisher","first-page":"e393","DOI":"10.1016\/S2665-9913(20)30164-8","volume":"2","author":"T Huet","year":"2020","unstructured":"Huet T, Beaussier H, Voisin O, Jouveshomme S, Dauriat G, Lazareth I et al (2020) Anakinra for severe forms of COVID-19: a cohort study. Lancet Rheumatol 2(7):e393\u2013e400","journal-title":"Lancet Rheumatol"},{"issue":"6 Pt 1","key":"992_CR57","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1067\/mai.2000.107604","volume":"105","author":"H Jiang","year":"2000","unstructured":"Jiang H, Harris MB, Rothman P (2000) IL-4\/IL-13 signaling beyond JAK\/STAT. J Allergy Clin Immunol 105(6 Pt 1):1063\u20131070","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"992_CR58","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.4049\/jimmunol.156.3.1110","volume":"156","author":"S Kanangat","year":"1996","unstructured":"Kanangat S, Thomas J, Gangappa S, Babu JS, Rouse BT (1996) Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J Immunol 156(3):1110\u20131116","journal-title":"J Immunol"},{"issue":"1","key":"992_CR59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.canlet.2013.08.045","volume":"342","author":"R Kariya","year":"2014","unstructured":"Kariya R, Taura M, Suzu S, Kai H, Katano H, Okada S (2014) HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-\u03baB pathway. Cancer Lett 342(1):52\u201359","journal-title":"Cancer Lett"},{"issue":"1","key":"992_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4110\/in.2011.11.1.1","volume":"11","author":"GY Kim","year":"2011","unstructured":"Kim GY, Hong C, Park JH (2011) Seeing is believing: illuminating the source of in vivo interleukin-7. Immune Netw 11(1):1\u201310","journal-title":"Immune Netw"},{"issue":"2","key":"992_CR61","doi-asserted-by":"publisher","first-page":"641","DOI":"10.4049\/jimmunol.175.2.641","volume":"175","author":"IL King","year":"2005","unstructured":"King IL, Segal BM (2005) Cutting edge: IL-12 induces CD4+CD25- T cell activation in the presence of T regulatory cells. J Immunol 175(2):641\u2013645","journal-title":"J Immunol"},{"issue":"7","key":"992_CR62","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1016\/S2665-9913(20)30160-0","volume":"2","author":"A King","year":"2020","unstructured":"King A, Vail A, O\u2019Leary C, Hannan C, Brough D, Patel H et al (2020) Anakinra in COVID-19: important considerations for clinical trials. Lancet Rheumatol 2(7):e379\u2013e381","journal-title":"Lancet Rheumatol"},{"key":"992_CR63","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.3389\/fimmu.2020.598444","volume":"11","author":"R Kircheis","year":"2020","unstructured":"Kircheis R, Haasbach E, Lueftenegger D, Heyken WT, Ocker M, Planz O (2020) NF-\u03baB pathway as a potential target for treatment of critical stage COVID-19 patients. Front Immunol 11:3446","journal-title":"Front Immunol"},{"issue":"12","key":"992_CR64","first-page":"4435","volume":"25","author":"D Kouroupis","year":"2021","unstructured":"Kouroupis D, Lanzoni G, Linetsky E, Messinger Cayetano S, Wishnek Metalonis S, Le\u00f1ero C (2021) Umbilical cord-derived mesenchymal stem cells modulate TNF and soluble TNF receptor 2 (sTNFR2) in COVID-19 ARDS patients. Eur Rev Med Pharmacol Sci 25(12):4435\u20134438","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"992_CR65","doi-asserted-by":"publisher","first-page":"e690","DOI":"10.1016\/S2665-9913(21)00216-2","volume":"3","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Huet T, Cavalli G, Gori A, Kyprianou M, Pickkers P et al (2021a) Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis. Lancet Rheumatol 3(10):e690\u2013e697","journal-title":"Lancet Rheumatol"},{"key":"992_CR66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66125","volume":"10","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Panagopoulos P, Metallidis S, Dalekos GN, Poulakou G, Gatselis N et al (2021b) An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife 10:e66125","journal-title":"Elife"},{"issue":"7","key":"992_CR67","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16485","volume":"3","author":"PF Laterre","year":"2020","unstructured":"Laterre PF, Fran\u00e7ois B, Collienne C, Hantson P, Jeannet R, Remy KE et al (2020) Association of interleukin 7 immunotherapy with lymphocyte counts among patients with severe coronavirus disease 2019 (COVID-19). JAMA Netw Open 3(7):e2016485","journal-title":"JAMA Netw Open"},{"issue":"5","key":"992_CR68","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.4049\/jimmunol.165.5.2783","volume":"165","author":"FN Lauw","year":"2000","unstructured":"Lauw FN, Pajkrt D, Hack CE, Kurimoto M, van Deventer SJ, van der Poll T (2000) Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 165(5):2783\u20132789","journal-title":"J Immunol"},{"issue":"6","key":"992_CR69","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a001651","volume":"1","author":"T Lawrence","year":"2009","unstructured":"Lawrence T (2009) The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 1(6):a001651","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2\u20133","key":"992_CR70","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S1359-6101(00)00027-7","volume":"12","author":"DE Levy","year":"2001","unstructured":"Levy DE, Garc\u00eda-Sastre A (2001) The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion. Cytokine Growth Factor Rev 12(2\u20133):143\u2013156","journal-title":"Cytokine Growth Factor Rev"},{"key":"992_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2020.155365","volume":"138","author":"Y Liu","year":"2021","unstructured":"Liu Y, Chen D, Hou J, Li H, Cao D, Guo M et al (2021) An inter-correlated cytokine network identified at the center of cytokine storm predicted COVID-19 prognosis. Cytokine 138:155365","journal-title":"Cytokine"},{"issue":"1","key":"992_CR72","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","volume":"42","author":"L Lu","year":"2021","unstructured":"Lu L, Zhang H, Dauphars DJ, He YW (2021) A Potential Role of Interleukin 10 in COVID-19 Pathogenesis. Trends Immunol 42(1):3\u20135","journal-title":"Trends Immunol"},{"issue":"7821","key":"992_CR73","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas C, Wong P, Klein J, Castro TB, Silva J, Sundaram M et al (2020) Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584(7821):463\u2013469","journal-title":"Nature"},{"issue":"7","key":"992_CR74","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/jmv.25801","volume":"92","author":"P Luo","year":"2020","unstructured":"Luo P, Liu Y, Qiu L, Liu X, Liu D, Li J (2020) Tocilizumab treatment in COVID-19: a single center experience. J Med Virol 92(7):814\u2013818","journal-title":"J Med Virol"},{"key":"992_CR75","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m1252","volume":"368","author":"E Mahase","year":"2020","unstructured":"Mahase E (2020) Covid-19: what treatments are being investigated? BMJ 368:m1252","journal-title":"BMJ"},{"issue":"5","key":"992_CR76","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1038\/pr.2015.143","volume":"78","author":"TC Mangodt","year":"2015","unstructured":"Mangodt TC, Van Herck MA, Nullens S, Ramet J, De Dooy JJ, Jorens PG et al (2015) The role of Th17 and Treg responses in the pathogenesis of RSV infection. Pediatr Res 78(5):483\u2013491","journal-title":"Pediatr Res"},{"issue":"1","key":"992_CR77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.immuni.2017.07.005","volume":"47","author":"CE Martin","year":"2017","unstructured":"Martin CE, Spasova DS, Frimpong-Boateng K, Kim HO, Lee M, Kim KS et al (2017) Interleukin-7 availability is maintained by a hematopoietic cytokine sink comprising innate lymphoid cells and T cells. Immunity 47(1):171\u201382.e4","journal-title":"Immunity"},{"issue":"3","key":"992_CR78","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.neuroscience.2006.10.037","volume":"144","author":"S Matsumura","year":"2007","unstructured":"Matsumura S, Shibakusa T, Fujikawa T, Yamada H, Inoue K, Fushiki T (2007) Increase in transforming growth factor-beta in the brain during infection is related to fever, not depression of spontaneous motor activity. Neuroscience 144(3):1133\u20131140","journal-title":"Neuroscience"},{"issue":"6","key":"992_CR79","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1164\/rccm.202005-1583OC","volume":"202","author":"OJ McElvaney","year":"2020","unstructured":"McElvaney OJ, McEvoy NL, McElvaney OF, Carroll TP, Murphy MP, Dunlea DM et al (2020) Characterization of the inflammatory response to severe COVID-19 illness. Am J Respir Crit Care Med 202(6):812\u2013821","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"992_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150018","volume":"11","author":"EA McKie","year":"2016","unstructured":"McKie EA, Reid JL, Mistry PC, DeWall SL, Abberley L, Ambery PD et al (2016) A study to investigate the efficacy and safety of an anti-interleukin-18 monoclonal antibody in the treatment of type 2 diabetes mellitus. PLoS ONE 11(3):e0150018","journal-title":"PLoS ONE"},{"issue":"4","key":"992_CR81","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1080\/14728222.2019.1586886","volume":"23","author":"J Medler","year":"2019","unstructured":"Medler J, Wajant H (2019) Tumor necrosis factor receptor-2 (TNFR2): an overview of an emerging drug target. Expert Opin Ther Targets 23(4):295\u2013307","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"992_CR82","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","volume":"50","author":"PM Miettunen","year":"2011","unstructured":"Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ (2011) Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology (oxford) 50(2):417\u2013419","journal-title":"Rheumatology (oxford)"},{"issue":"3","key":"992_CR83","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/CCM.0000000000001409","volume":"44","author":"C Mikacenic","year":"2016","unstructured":"Mikacenic C, Hansen EE, Radella F, Gharib SA, Stapleton RD, Wurfel MM (2016) Interleukin-17A is associated with alveolar inflammation and poor outcomes in acute respiratory distress syndrome. Crit Care Med 44(3):496\u2013502","journal-title":"Crit Care Med"},{"key":"992_CR84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejim.2020.05.011","volume":"76","author":"V Morena","year":"2020","unstructured":"Morena V, Milazzo L, Oreni L, Bestetti G, Fossali T, Bassoli C et al (2020) Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy. Eur J Intern Med 76:36\u201342","journal-title":"Eur J Intern Med"},{"key":"992_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2020.110111","volume":"143","author":"N Mozafari","year":"2020","unstructured":"Mozafari N, Azadi S, Mehdi-Alamdarlou S, Ashrafi H, Azadi A (2020) Inflammation: a bridge between diabetes and COVID-19, and possible management with sitagliptin. Med Hypotheses 143:110111","journal-title":"Med Hypotheses"},{"issue":"4","key":"992_CR86","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1164\/rccm.201410-1782OC","volume":"193","author":"R Muir","year":"2016","unstructured":"Muir R, Osbourn M, Dubois AV, Doran E, Small DM, Monahan A et al (2016) Innate lymphoid cells are the predominant source of IL-17A during the early pathogenesis of acute respiratory distress syndrome. Am J Respir Crit Care Med 193(4):407\u2013416","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"992_CR87","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.coph.2006.01.010","volume":"6","author":"PJ Murray","year":"2006","unstructured":"Murray PJ (2006) Understanding and exploiting the endogenous interleukin-10\/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6(4):379\u2013386","journal-title":"Curr Opin Pharmacol"},{"key":"992_CR88","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","volume":"9","author":"K Nakanishi","year":"2018","unstructured":"Nakanishi K (2018) Unique action of interleukin-18 on T cells and other immune cells. Front Immunol 9:763","journal-title":"Front Immunol"},{"issue":"12","key":"992_CR89","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/art.41422","volume":"72","author":"I Navarro-Mill\u00e1n","year":"2020","unstructured":"Navarro-Mill\u00e1n I, Sattui SE, Lakhanpal A, Zisa D, Siegel CH, Crow MK (2020) Use of anakinra to prevent mechanical ventilation in severe COVID-19: a case series. Arthritis Rheumatol 72(12):1990\u20131997","journal-title":"Arthritis Rheumatol"},{"key":"992_CR90","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25870","author":"T Nawar","year":"2020","unstructured":"Nawar T, Morjaria S, Kaltsas A, Patel D, Perez-Johnston R, Daniyan AF et al (2020) Granulocyte-colony stimulating factor in COVID-19: is it stimulating more than just the bone marrow? Am J Hematol. https:\/\/doi.org\/10.1002\/ajh.25870","journal-title":"Am J Hematol"},{"issue":"5","key":"992_CR91","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004077","volume":"10","author":"JL Nieto-Torres","year":"2014","unstructured":"Nieto-Torres JL, DeDiego ML, Verdi\u00e1-B\u00e1guena C, Jimenez-Guarde\u00f1o JM, Regla-Nava JA, Fernandez-Delgado R et al (2014) Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog 10(5):e1004077","journal-title":"PLoS Pathog"},{"issue":"7","key":"992_CR92","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1016\/j.cell.2015.12.004","volume":"163","author":"LA O'Neill","year":"2015","unstructured":"O\u2019Neill LA (2015) How low cholesterol is good for anti-viral immunity. Cell 163(7):1572\u20131574","journal-title":"Cell"},{"issue":"4","key":"992_CR93","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","volume":"117","author":"SM Opal","year":"2000","unstructured":"Opal SM, DePalo VA (2000) Anti-inflammatory cytokines. Chest 117(4):1162\u20131172","journal-title":"Chest"},{"issue":"6","key":"992_CR94","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41577-020-0328-z","volume":"20","author":"O Pacha","year":"2020","unstructured":"Pacha O, Sallman MA, Evans SE (2020) COVID-19: a case for inhibiting IL-17? Nat Rev Immunol 20(6):345\u2013346","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"992_CR95","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.immuni.2004.07.016","volume":"21","author":"JH Park","year":"2004","unstructured":"Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, Grimes HL et al (2004) Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21(2):289\u2013302","journal-title":"Immunity"},{"issue":"6","key":"992_CR96","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3390\/ijms22063059","volume":"22","author":"C Pelaia","year":"2021","unstructured":"Pelaia C, Calabrese C, Garofalo E, Bruni A, Vatrella A, Pelaia G (2021) Therapeutic role of tocilizumab in SARS-CoV-2-induced cytokine storm: rationale and current evidence. Int J Mol Sci 22(6):3059","journal-title":"Int J Mol Sci"},{"issue":"1","key":"992_CR97","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s12967-020-02573-9","volume":"18","author":"F Perrone","year":"2020","unstructured":"Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM et al (2020) Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial. J Transl Med 18(1):405","journal-title":"J Transl Med"},{"issue":"4","key":"992_CR98","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jinf.2021.02.023","volume":"82","author":"L Petrone","year":"2021","unstructured":"Petrone L, Petruccioli E, Alonzi T, Vanini V, Cuzzi G, Najafi Fard S et al (2021) In-vitro evaluation of the immunomodulatory effects of baricitinib: implication for COVID-19 therapy. J Infect 82(4):58\u201366","journal-title":"J Infect"},{"issue":"4","key":"992_CR99","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/ddr.21794","volume":"82","author":"P Prasher","year":"2021","unstructured":"Prasher P, Sharma M, Gunupuru R (2021) Targeting cyclooxygenase enzyme for the adjuvant COVID-19 therapy. Drug Dev Res 82(4):469\u2013473","journal-title":"Drug Dev Res"},{"issue":"15","key":"992_CR100","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"C Qin","year":"2020","unstructured":"Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y et al (2020) Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis 71(15):762\u2013768","journal-title":"Clin Infect Dis"},{"issue":"5","key":"992_CR101","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3390\/vaccines9050436","volume":"9","author":"AA Rabaan","year":"2021","unstructured":"Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R et al (2021) Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (basel) 9(5):436","journal-title":"Vaccines (basel)"},{"issue":"1","key":"992_CR102","first-page":"1","volume":"8","author":"S Ramalingam","year":"2018","unstructured":"Ramalingam S, Cai B, Wong J, Twomey M, Chen R, Fu RM et al (2018) Antiviral innate immune response in non-myeloid cells is augmented by chloride ions via an increase in intracellular hypochlorous acid levels. Sci Rep 8(1):1\u201311","journal-title":"Sci Rep"},{"key":"992_CR103","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.14.20099234","author":"M Ramaswamy","year":"2020","unstructured":"Ramaswamy M, Mannam P, Comer R, Sinclair E, McQuaid DB, Schmidt ML (2020) Off-label real world experience using tocilizumab for patients hospitalized with COVID-19 disease in a regional community health system: a case-control study. Medrxiv. https:\/\/doi.org\/10.1101\/2020.05.14.20099234","journal-title":"Medrxiv"},{"key":"992_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jri.2020.103213","volume":"142","author":"K Renu","year":"2020","unstructured":"Renu K, Subramaniam MD, Chakraborty R, Myakala H, Iyer M, Bharathi G et al (2020a) The role of Interleukin-4 in COVID-19 associated male infertility: a hypothesis. J Reprod Immunol 142:103213","journal-title":"J Reprod Immunol"},{"key":"992_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117839","volume":"255","author":"K Renu","year":"2020","unstructured":"Renu K, Prasanna PL, Valsala GA (2020b) Coronaviruses pathogenesis, comorbidities and multi-organ damage: a review. Life Sci 255:117839","journal-title":"Life Sci"},{"issue":"1","key":"992_CR106","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41423-019-0347-5","volume":"18","author":"E Robins","year":"2021","unstructured":"Robins E, Zheng M, Ni Q, Liu S, Liang C, Zhang B et al (2021) Conversion of effector CD4(+) T cells to a CD8(+) MHC II-recognizing lineage. Cell Mol Immunol 18(1):150\u2013161","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"992_CR107","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000247156","volume":"2","author":"CM Robinson","year":"2010","unstructured":"Robinson CM, O\u2019Dee D, Hamilton T, Nau GJ (2010) Cytokines involved in interferon-gamma production by human macrophages. J Innate Immun 2(1):56\u201365","journal-title":"J Innate Immun"},{"key":"992_CR108","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2584","volume":"4","author":"T Rognes","year":"2016","unstructured":"Rognes T, Flouri T, Nichols B, Quince C, Mah\u00e9 F (2016) VSEARCH: a versatile open source tool for metagenomics. PeerJ 4:e2584","journal-title":"PeerJ"},{"issue":"5","key":"992_CR109","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","volume":"46","author":"Q Ruan","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J (2020) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan. China Intensive Care Med 46(5):846\u2013848","journal-title":"China Intensive Care Med"},{"issue":"16","key":"992_CR110","doi-asserted-by":"publisher","first-page":"8998","DOI":"10.1128\/JVI.00534-14","volume":"88","author":"YB Seo","year":"2014","unstructured":"Seo YB, Im SJ, Namkoong H, Kim SW, Choi YW, Kang MC et al (2014) Crucial roles of interleukin-7 in the development of T follicular helper cells and in the induction of humoral immunity. J Virol 88(16):8998\u20139009","journal-title":"J Virol"},{"key":"992_CR111","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.3389\/fimmu.2019.02897","volume":"10","author":"A Sheikh","year":"2019","unstructured":"Sheikh A, Abraham N (2019) Interleukin-7 receptor alpha in innate lymphoid cells: more than a marker. Front Immunol 10:2897","journal-title":"Front Immunol"},{"key":"992_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.671788","volume":"9","author":"WX Shen","year":"2021","unstructured":"Shen WX, Luo RC, Wang JQ, Chen ZS (2021) Features of cytokine storm identified by distinguishing clinical manifestations in COVID-19. Front Public Health 9:671788","journal-title":"Front Public Health"},{"issue":"2","key":"992_CR113","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3109\/08977194.2015.1010645","volume":"33","author":"J Sheng","year":"2015","unstructured":"Sheng J, Chen W, Zhu HJ (2015) The immune suppressive function of transforming growth factor-\u03b2 (TGF-\u03b2) in human diseases. Growth Factors 33(2):92\u2013101","journal-title":"Growth Factors"},{"key":"992_CR114","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fphar.2017.00827","volume":"8","author":"A Sinniah","year":"2017","unstructured":"Sinniah A, Yazid S, Flower RJ (2017) The anti-allergic cromones: past, present, and future. Front Pharmacol 8:827","journal-title":"Front Pharmacol"},{"issue":"8","key":"992_CR115","doi-asserted-by":"publisher","first-page":"8865","DOI":"10.1096\/fj.201802418R","volume":"33","author":"KL Siu","year":"2019","unstructured":"Siu KL, Yuen KS, Castano-Rodriguez C, Ye ZW, Yeung ML, Fung SY et al (2019) Severe acute respiratory syndrome Coronavirus ORF3a protein activates the NLRP3 inflammasome by promoting TRAF3-dependent ubiquitination of ASC. FASEB J 33(8):8865\u20138877","journal-title":"FASEB J"},{"issue":"12","key":"992_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005973","volume":"12","author":"J Slaats","year":"2016","unstructured":"Slaats J, Ten Oever J, van de Veerdonk FL, Netea MG (2016) IL-1\u03b2\/IL-6\/CRP and IL-18\/ferritin: distinct Inflammatory programs in infections. PLoS Pathog 12(12):e1005973","journal-title":"PLoS Pathog"},{"issue":"4","key":"992_CR117","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1155\/2002\/941087","volume":"16","author":"AW Stadnyk","year":"2002","unstructured":"Stadnyk AW (2002) Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol 16(4):241\u2013246","journal-title":"Can J Gastroenterol"},{"key":"992_CR118","volume":"31","author":"M Taha","year":"2020","unstructured":"Taha M, Sharma A, Soubani A (2020) Clinical deterioration during neutropenia recovery after G-CSF therapy in patient with COVID-19. Respir Med Case Rep 31:101231","journal-title":"Respir Med Case Rep"},{"issue":"6","key":"992_CR119","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay MZ, Poh CM, R\u00e9nia L, MacAry PA, Ng LFP (2020) The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol 20(6):363\u2013374","journal-title":"Nat Rev Immunol"},{"issue":"7","key":"992_CR120","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102568","volume":"19","author":"P Toniati","year":"2020","unstructured":"Toniati P, Piva S, Cattalini M, Garrafa E, Regola F, Castelli F et al (2020) Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy. Autoimmun Rev 19(7):102568","journal-title":"Autoimmun Rev"},{"issue":"8","key":"992_CR121","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.4049\/jimmunol.1303343","volume":"194","author":"CY Tsai","year":"2015","unstructured":"Tsai CY, Liong KH, Gunalan MG, Li N, Lim DS, Fisher DA et al (2015) Type I IFNs and IL-18 regulate the antiviral response of primary human \u03b3\u03b4 T cells against dendritic cells infected with Dengue virus. J Immunol 194(8):3890\u20133900","journal-title":"J Immunol"},{"key":"992_CR122","first-page":"2563","volume":"11","author":"MD Turner","year":"1843","unstructured":"Turner MD, Nedjai B, Hurst T, Pennington DJ (1843) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochimica Et Biophysica Acta (BBA) 11:2563\u20132582","journal-title":"Biochimica Et Biophysica Acta (BBA)"},{"issue":"6","key":"992_CR123","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.immuni.2020.05.002","volume":"52","author":"N Vabret","year":"2020","unstructured":"Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M et al (2020) Immunology of COVID-19: current state of the science. Immunity 52(6):910\u2013941","journal-title":"Immunity"},{"issue":"1","key":"992_CR124","first-page":"55","volume":"24","author":"B Van den Borne","year":"1997","unstructured":"Van den Borne B, Dijkmans B, De Rooij H, Le Cessie S, Verweij C (1997) Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells. J Rheumatol 24(1):55\u201360","journal-title":"J Rheumatol"},{"issue":"1","key":"992_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2018.289","volume":"5","author":"E Van Quickelberghe","year":"2018","unstructured":"Van Quickelberghe E, De Sutter D, van Loo G, Eyckerman S, Gevaert K (2018) A protein-protein interaction map of the TNF-induced NF-\u03baB signal transduction pathway. Sci Data 5(1):180289","journal-title":"Sci Data"},{"key":"992_CR126","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.bbamem.2010.05.006","volume":"2","author":"K Wang","year":"2011","unstructured":"Wang K, Xie S, Sun B (2011) Viral proteins function as ion channels. Biochimica Et Biophysica Acta (BBA) 2:510\u2013515","journal-title":"Biochimica Et Biophysica Acta (BBA)"},{"key":"992_CR127","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137799","author":"F Wang","year":"2020","unstructured":"Wang F, Hou H, Luo Y, Tang G, Wu S, Huang M et al (2020) The laboratory tests and host immunity of COVID-19 patients with different severity of illness. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.137799","journal-title":"JCI Insight"},{"issue":"12","key":"992_CR128","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.4049\/jimmunol.147.12.4229","volume":"147","author":"CF Ware","year":"1991","unstructured":"Ware CF, Crowe PD, Vanarsdale TL, Andrews JL, Grayson MH, Jerzy R et al (1991) Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells. J Immunol 147(12):4229\u20134238","journal-title":"J Immunol"},{"issue":"8","key":"992_CR129","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/resp.13875","volume":"25","author":"TR Wiche Salinas","year":"2020","unstructured":"Wiche Salinas TR, Zheng B, Routy JP, Ancuta P (2020) Targeting the interleukin-17 pathway to prevent acute respiratory distress syndrome associated with SARS-CoV-2 infection. Respirology 25(8):797\u2013799","journal-title":"Respirology"},{"issue":"15","key":"992_CR130","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/onc.2009.29","volume":"28","author":"A Wicovsky","year":"2009","unstructured":"Wicovsky A, Henkler F, Salzmann S, Scheurich P, Kneitz C, Wajant H (2009) Tumor necrosis factor receptor-associated factor-1 enhances proinflammatory TNF receptor-2 signaling and modifies TNFR1\u2013TNFR2 cooperation. Oncogene 28(15):1769\u20131781","journal-title":"Oncogene"},{"issue":"1","key":"992_CR131","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2249.2004.02415.x","volume":"136","author":"CK Wong","year":"2004","unstructured":"Wong CK, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH et al (2004) Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin Exp Immunol 136(1):95\u2013103","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"992_CR132","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jmii.2020.03.005","volume":"53","author":"D Wu","year":"2020","unstructured":"Wu D, Yang XO (2020) TH17 responses in cytokine storm of COVID-19: an emerging target of JAK2 inhibitor fedratinib. J Microbiol Immunol Infect 53(3):368\u2013370","journal-title":"J Microbiol Immunol Infect"},{"key":"992_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.dib.2020.105953","volume":"31","author":"X Xiong","year":"2020","unstructured":"Xiong X, Chua GT, Chi S, Kwan MYW, Wong WHS, Zhou A et al (2020) Haematological and immunological data of Chinese children infected with coronavirus disease 2019. Data Brief 31:105953","journal-title":"Data Brief"},{"issue":"3","key":"992_CR134","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/ijms20030649","volume":"20","author":"K Yasuda","year":"2019","unstructured":"Yasuda K, Nakanishi K, Tsutsui H (2019) Interleukin-18 in health and disease. Int J Mol Sci. 20(3):649","journal-title":"Int J Mol Sci."},{"issue":"6","key":"992_CR135","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Q Ye","year":"2020","unstructured":"Ye Q, Wang B, Mao J (2020) The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J Infect 80(6):607\u2013613","journal-title":"J Infect"},{"key":"992_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108517","volume":"218","author":"S Yeleswaram","year":"2020","unstructured":"Yeleswaram S, Smith P, Burn T, Covington M, Juvekar A, Li Y et al (2020) Inhibition of cytokine signaling by ruxolitinib and implications for COVID-19 treatment. Clin Immunol 218:108517","journal-title":"Clin Immunol"},{"issue":"9","key":"992_CR137","doi-asserted-by":"publisher","first-page":"e2932","DOI":"10.1093\/cid\/ciaa1280","volume":"73","author":"BE Young","year":"2021","unstructured":"Young BE, Ong SWX, Ng LFP, Anderson DE, Chia WN, Chia PY et al (2021) Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity. Clin Infect Dis 73(9):e2932\u2013e2942","journal-title":"Clin Infect Dis"},{"key":"992_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114296","volume":"183","author":"H Yousefi","year":"2021","unstructured":"Yousefi H, Mashouri L, Okpechi SC, Alahari N, Alahari SK (2021) Repurposing existing drugs for the treatment of COVID-19\/SARS-CoV-2 infection: a review describing drug mechanisms of action. Biochem Pharmacol 183:114296","journal-title":"Biochem Pharmacol"},{"issue":"8","key":"992_CR139","doi-asserted-by":"publisher","first-page":"4410","DOI":"10.1128\/IAI.72.8.4410-4415.2004","volume":"72","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Li J, Zhan Y, Wu L, Yu X, Zhang W et al (2004) Analysis of serum cytokines in patients with severe acute respiratory syndrome. Infect Immun 72(8):4410\u20134415","journal-title":"Infect Immun"},{"issue":"6515","key":"992_CR140","doi-asserted-by":"publisher","first-page":"eabd4570","DOI":"10.1126\/science.abd4570","volume":"370","author":"Q Zhang","year":"2020","unstructured":"Zhang Q, Bastard P, Liu Z, Le Pen J, Moncada-Velez M, Chen J et al (2020a) Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370(6515):eabd4570","journal-title":"Science"},{"key":"992_CR141","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108393","volume":"214","author":"W Zhang","year":"2020","unstructured":"Zhang W, Zhao Y, Zhang F, Wang Q, Li T, Liu Z et al (2020b) The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): the perspectives of clinical immunologists from China. Clin Immunol 214:108393","journal-title":"Clin Immunol"},{"issue":"6","key":"992_CR142","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s40261-020-00917-3","volume":"40","author":"S Zhang","year":"2020","unstructured":"Zhang S, Li L, Shen A, Chen Y, Qi Z (2020c) Rational use of tocilizumab in the treatment of novel coronavirus pneumonia. Clin Drug Investig 40(6):511\u2013518","journal-title":"Clin Drug Investig"},{"key":"992_CR143","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117583","volume":"250","author":"R Zhang","year":"2020","unstructured":"Zhang R, Wang X, Ni L, Di X, Ma B, Niu S et al (2020d) COVID-19: melatonin as a potential adjuvant treatment. Life Sci 250:117583","journal-title":"Life Sci"},{"key":"992_CR144","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139834","author":"Y Zhao","year":"2020","unstructured":"Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J et al (2020) Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.139834","journal-title":"JCI Insight"},{"issue":"5","key":"992_CR145","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","volume":"17","author":"YY Zheng","year":"2020","unstructured":"Zheng YY, Ma YT, Zhang JY, Xie X (2020) COVID-19 and the cardiovascular system. Nat Rev Cardiol 17(5):259\u2013260","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"992_CR146","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","volume":"21","author":"Z Zhu","year":"2020","unstructured":"Zhu Z, Lian X, Su X, Wu W, Marraro GA, Zeng Y (2020) From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses. Respir Res 21(1):224","journal-title":"Respir Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00992-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-00992-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00992-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T09:49:21Z","timestamp":1675504161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-00992-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":146,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["992"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-00992-2","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"assertion":[{"value":"2 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have not disclosed any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}